{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:45:03Z","timestamp":1792683903149,"version":"4.5.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>T cells engineered with chimeric antigen receptor (CAR-T cells) are an effective treatment in patients with relapsed\/refractory B-cell precursor acute lymphoblastic leukemia or B-cell non-Hodgkin lymphoma. Despite the reported exciting clinical results, the CAR-T cell approach needs efforts to improve the safety profile, limiting the occurrence of adverse events in patients given this treatment. Besides the most common side effects, such as cytokine release syndrome and CAR-T cell\u2013related encephalopathy syndrome, another potential issue involves the inadvertent transduction of leukemia B cells with the CAR construct during the manufacturing process, thus leading to the possibility of a peculiar mechanism of antigen masking and treatment resistance. In this study, we investigated whether the inclusion of the inducible caspase 9 (iC9) suicide gene in the CAR construct design could be an effective safety switch to control malignant CAR+ B cells, ultimately counteracting this serious adverse event. iC9 is a suicide gene able to be activated through binding with an otherwise inert small biomolecule, known as AP1903. The exposure of iC9.CAR.CD19-DAUDI lymphoma and iC9.CAR.CD19-NALM-6 leukemia cells <jats:italic>in vitro<\/jats:italic> to 20 nM of AP1903 resulted into the prompt elimination of CAR<jats:sup>+<\/jats:sup> B-leukemia\/lymphoma cell lines. The results obtained in the animal model corroborate <jats:italic>in vitro<\/jats:italic> data, since iC9.CAR.CD19<jats:sup>+<\/jats:sup> tumor cells were controlled <jats:italic>in vivo<\/jats:italic> by the activation of the suicide gene through administration of AP1903. Altogether, our data indicate that the inclusion of the iC9 suicide gene may result in a safe CAR-T cell product, even when manufacturing starts from biological materials characterized by heavy leukemia blast contamination.<\/jats:p>","DOI":"10.3389\/fimmu.2021.755639","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T22:02:01Z","timestamp":1634767321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":75,"title":["Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies"],"prefix":"10.3389","volume":"12","author":[{"given":"Marika","family":"Guercio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Manni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Di Cecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Sinibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Abbaszadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Camera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselia","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicia Assunta","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ferrandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Reddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luigia","family":"Catanoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Bocceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Del Bufalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Algeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Quintarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01594","article-title":"Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions","volume":"10","author":"Greenbaum","year":"2020","journal-title":"Front Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0201-9","article-title":"Induction of Resistance to Chimeric Antigen Receptor T Cell Therapy by Transduction of a Single Leukemic B Cell","volume":"24","author":"Ruella","year":"2018","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001514","article-title":"Strategy to Prevent Epitope Masking in CAR.CD19+ B-Cell Leukemia Blasts","volume":"9","author":"Quintarelli","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00254","article-title":"Improving the Safety of Cell Therapy Products by Suicide Gene Transfer","volume":"5","author":"Jones","year":"2014","journal-title":"Front Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4564","article-title":"An Inducible Caspase 9 Safety Switch for T-Cell Therapy","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-551671","article-title":"Long-Term Outcome After Haploidentical Stem Cell Transplant and Infusion of T Cells Expressing the Inducible Caspase 9 Safety Transgene","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.231183","article-title":"CD28.OX40 Co-Stimulatory Combination Is Associated With Long In Vivo Persistence and High Activity of CAR.CD30 T-Cells","volume":"106","author":"Guercio","year":"2021","journal-title":"Haematologica"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083413","article-title":"Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration","volume":"300","author":"Wu","year":"2003","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-068759","article-title":"Hot Spots of Retroviral Integration in Human CD34+ Hematopoietic Cells","volume":"110","author":"Cattoglio","year":"2007","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0507496103","article-title":"Retroviral Vector Integration Deregulates Gene Expression But Has No Consequence on the Biology and Function of Transplanted T Cells","volume":"103","author":"Recchia","year":"2006","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31661","article-title":"Gammaretrovirus-Mediated Correction of SCID-X1 is Associated With Skewed Vector Integration Site Distribution","volume":"117","author":"Schwarzwaelder","year":"2007","journal-title":"Vivo J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00235","article-title":"The Inducible Caspase-9 Suicide Gene System as a \u201cSafety Switch\u201d to Limit on-Target, Off-Tumor Toxicities of Chimeric Antigen Receptor T Cells","volume":"5","author":"Gargett","year":"2014","journal-title":"Front Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0613-7","article-title":"Efficacy of Third-Party Chimeric Antigen Receptor Modified Peripheral Blood Natural Killer Cells for Adoptive Cell Therapy of B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"34","author":"Quintarelli","year":"2020","journal-title":"Leukemia"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122010771","article-title":"Intravenous Safety and Pharmacokinetics of a Novel Dimerizer Drug, AP1903, in Healthy Volunteers","volume":"41","author":"Iuliucci","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/hgtb.2012.050","article-title":"Comparison of Different Suicide-Gene Strategies for the Safety Improvement of Genetically Manipulated T Cells","volume":"23","author":"Marin","year":"2012","journal-title":"Hum Gene Ther Methods"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-011-0692-z","article-title":"Targeting Colorectal Cancer Stem Cells With Inducible Caspase-9","volume":"17","author":"Kemper","year":"2012","journal-title":"Apoptosis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.234","article-title":"Serial Activation of the Inducible Caspase 9 Safety Switch After Human Stem Cell Transplantation","volume":"24","author":"Zhou","year":"2016","journal-title":"Mol Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.755639\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T22:02:06Z","timestamp":1634767326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.755639\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":17,"alternative-id":["10.3389\/fimmu.2021.755639"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.755639","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"article-number":"755639"}}